Trading JournalIt was trying to change the trend in the AM with big spike in volume and price
general market weakness results in continous sell off
sold for -4% loss
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.99 USD
−25.03 M USD
241.62 M USD
32.43 M
About TransMedics Group, Inc.
Sector
Industry
CEO
Waleed H. Hassanein
Website
Headquarters
Andover
Founded
1998
FIGI
BBG00NZ6J685
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
12/5/24 - $tmdx - I'm back... buying sub $7012/5/24 :: VROCKSTAR :: NASDAQ:TMDX
I'm back... buying sub $70
- check out last post when i opportunistically bot this thing
- some Q's on last call ppl pointing out about "seasonality" being a bit sus. interesting. yeah CEO did act a bit defensive and i don't have context or know the chad
- but
Catching the TransMedics Group - $TMDX Falling KnifeTransMedics Group - NASDAQ:TMDX
For current and new shareholders here is your buying range for this company.
This could be the bounce that sends us back towards ATH's. But, if we were to fall lower I think it would be capped out around the 200MA.
DCA Buying Range: $55-$90
AVP GAP Fill to $13
TMDXNASDAQ:TMDX is likely heading lower to complete the impulse in the wave C of a running flat. I will start buying within the range $60-70.
There are two typical dimensions for the wave C of a flat - wC=wA or times 1,618.
Zooming in the daily/ 4h frame - there is a clear impulsive move down, that is
Call the TransMedicsInteresting stock, the high growth that propelled it to a 600% plus gain is slowing down. Management claim it’s due to seasonal pressure, not sure if I can believe there’s a season for organ donors but now I know there is!
We’ve since had a 50% haircut in the last month. It’s going to be a turbulen
10/30/24 - $tmdx - Buying 11/15 C's sub $8510/30/24 :: VROCKSTAR :: NASDAQ:TMDX
Buying 11/15 C's sub $85
- this price action looks VERY similar to all the stonks that are getting rekt beyond the 25% threshold. it's incredible how similarly the mkt treats these things. by mkt i mean the AGI that controls us all at this pt and nobody wants
My Watchlist: TMDXTMDX, an IBD50 stock has a setup now (1). I'm looking to enter long near the close of the day if the stock can manage to CLOSE above the last candle highs(2). If triggered, I will then place a stop-loss below (3) and a price target above it (4).
finally positive earningsbounce of 10 ema after big move. Small 2.5% position 8% max risk
stop is close under 10 ema. or hard stop.
$TMDX Strong stock move from this organ transport companyNASDAQ:TMDX This is a green ants stock. So one of the top stocks on my list.
No pullback and looks like going up farther more after earnings gap up. But since it is very extended I will keep stops very tight. Prefer a decent pullback and then bounce.
TMDX, 5/8-5/17, 9.5% ProfitOn 4/30/2024, TransMedics Group (TMDX) reported earnings of $0.35 per share on revenue of $96.85 million for the first quarter ended March 2024. The consensus estimate was a loss of $0.05 per share on revenue of $83.32 million.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TMDX is 61.70 USD — it has increased by 1.93% in the past 24 hours. Watch TransMedics Group, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange TransMedics Group, Inc. stocks are traded under the ticker TMDX.
TMDX stock has fallen by −5.90% compared to the previous week, the month change is a −23.72% fall, over the last year TransMedics Group, Inc. has showed a −22.11% decrease.
We've gathered analysts' opinions on TransMedics Group, Inc. future price: according to them, TMDX price has a max estimate of 125.00 USD and a min estimate of 75.00 USD. Watch TMDX chart and read a more detailed TransMedics Group, Inc. stock forecast: see what analysts think of TransMedics Group, Inc. and suggest that you do with its stocks.
TMDX reached its all-time high on Aug 23, 2024 with the price of 177.37 USD, and its all-time low was 10.00 USD and was reached on Feb 24, 2022. View more price dynamics on TMDX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TMDX stock is 4.65% volatile and has beta coefficient of 1.71. Track TransMedics Group, Inc. stock price on the chart and check out the list of the most volatile stocks — is TransMedics Group, Inc. there?
Today TransMedics Group, Inc. has the market capitalization of 2.07 B, it has decreased by −2.46% over the last week.
Yes, you can track TransMedics Group, Inc. financials in yearly and quarterly reports right on TradingView.
TransMedics Group, Inc. is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
TMDX earnings for the last quarter are 0.12 USD per share, whereas the estimation was 0.29 USD resulting in a −59.10% surprise. The estimated earnings for the next quarter are 0.16 USD per share. See more details about TransMedics Group, Inc. earnings.
TransMedics Group, Inc. revenue for the last quarter amounts to 108.76 M USD, despite the estimated figure of 115.00 M USD. In the next quarter, revenue is expected to reach 109.49 M USD.
TMDX net income for the last quarter is 4.22 M USD, while the quarter before that showed 12.19 M USD of net income which accounts for −65.43% change. Track more TransMedics Group, Inc. financial stats to get the full picture.
No, TMDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 584.00 employees. See our rating of the largest employees — is TransMedics Group, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TransMedics Group, Inc. EBITDA is 49.34 M USD, and current EBITDA margin is 3.63%. See more stats in TransMedics Group, Inc. financial statements.
Like other stocks, TMDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TransMedics Group, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TransMedics Group, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TransMedics Group, Inc. stock shows the sell signal. See more of TransMedics Group, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.